Last update 21 Nov 2024
PIT-565
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Trispecific T-cell engager (TriTE) |
Synonyms |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD2 agonists(T-cell surface antigen CD2 agonists), CD3 stimulants(T cell surface glycoprotein CD3 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with PIT-565A Phase Ib, Open-label, Ascending Dose Study With Step-up Doses to Assess Safety, Tolerability, and Pharmacokinetics of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
- CPIT565A12101
A Phase I, Open-label, Multi-center Study of PIT565 in Patients With Relapsed and/or Refractory B-cell Malignancies
100 Clinical Results associated with PIT-565
Login to view more data
100 Translational Medicine associated with PIT-565
Login to view more data
100 Patents (Medical) associated with PIT-565
Login to view more data
100 Deals associated with PIT-565
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Lymphoma | Phase 1 | IT | 03 Oct 2022 | |
| B-Cell Lymphoma | Phase 1 | BE | 03 Oct 2022 | |
| B-Cell Lymphoma | Phase 1 | IL | 03 Oct 2022 | |
| B-Cell Lymphoma | Phase 1 | US | 03 Oct 2022 | |
| B-Cell Lymphoma | Phase 1 | JP | 03 Oct 2022 | |
| B-Cell Lymphoma | Phase 1 | FR | 03 Oct 2022 | |
| B-Cell Lymphoma | Phase 1 | SG | 03 Oct 2022 | |
| B-Cell Lymphoma | Phase 1 | ES | 03 Oct 2022 | |
| Pre B-cell acute lymphoblastic leukemia | Phase 1 | BE | 03 Oct 2022 | |
| Pre B-cell acute lymphoblastic leukemia | Phase 1 | SG | 03 Oct 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free